Keywords: Medicnes Australia, Competition Commission, Code of Conduct, Marketing

Australian pharma industry embraces tougher Code of Conduct

Article | 4 December 2009

The Australian Competition and Consumer Commission this week said that it has decided to grant authorization for five years to pharmaceutical trade group Medicines Australia's 16th edition of its Code of Conduct. The Code sets standards for the marketing and promotion of prescription medicinal products in Australia.

The Code provides, among other things, a standard to address potential conflicts of interest from unrestricted relationships between pharmaceutical companies and health care professionals, which may harm consumers, for example through inappropriate prescribing by health care professionals. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in